Enhance patient recruitment and retention with digital vascular biomarkers.

Enhance patient recruitment and retention with digital vascular biomarkers.

Enroll the Right Patient in the Right Trial Using Digital Vascular Biomarkers

ATCOR medical devices and digital solutions provide easy, accurate, and consistent monitoring and notification alerts of essential patient vital signs across all trial designs - conventional, hybrid, decentralized, and Real-World Evidence.

Real-World Evidence (RWE)

  • Improve patient outcomes
  • Personalize the patient healthcare journey
  • Identify patient risk early
  • Enhance patient recruitment

Clinical Trials

  • Design inclusion/exclusion criteria with digital vascular biomarkers
  • Improve patient retention
  • Decrease adverse events
  • Increase patient engagement

Conventional, hybrid, and decentralized trials focus on patient outcomes using ATCOR’s SphygmoCor Technology

ATCOR’s Clinical Trial Services

We provide a comprehensive suite of services for digital vascular biomarker collection for clinical trials.

Design & Development

  • Protocol design assistance
  • Study-specific user manuals and training materials

Training & Certification

  • Study-specific training
  • Operator certification

Reliable QC Data Services

  • Full-service collection and delivery of top-quality data
  • Ease of measurement lowers patient burden and increases compliance

Technical Experience

  • Dedicated team of technical experts - 15 years’ experience
  • Involvement in all phases of trial implementation

Global Implementation & Support

  • Equipment logistics
  • Simple, encrypted data transfer
  • 24/7 site support
  • Fully configured devices for turn-key trial site use

ATCOR’s digital vascular biomarkers benefit patients everywhere

SphygmoCor at a Glance

All “Top 20 Hospitals” use SphygmoCor technology to measure central blood pressure (cBP)

1,400+ studies using the SphygmoCor technology have been published in peer-reviewed clinical publications.

8 out of Top 10 Pharma companies have used SphygmoCor technology in their clinical trials

Over 11,000 patients have been tested with SphygmoCor technology in pharmaceutical trials

Over 30 Years of Technology Leadership and Partnerships

Want to Learn More?

By submitting this form, you consent to our Privacy Policy and Terms & Conditions